PRP and MFAT Treatments Explained for Workers

PRP for the Picker’s Shoulder vs. MFAT for the Technician’s Knee

Abstract: A warehouse picker with shoulder pain and a data center technician with a painful knee may both ask about “regenerative” treatment, but they may need different procedures. This guide explains how platelet-rich plasma (PRP) and microfragmented adipose tissue (MFAT) differ, why diagnosis and tissue severity matter, and how rehabilitation supports a safe return to lifting, climbing, squatting, and training.

Two workers can be equally tough and equally frustrated by pain—and still need completely different treatment plans.

Picture an Amazon picker whose shoulder burns after hundreds of reaches and overhead movements. Now picture a data center technician whose knee aches after kneeling, ladder work, squatting, and carrying equipment. Both may have tried rehabilitation.

The mistake is assuming that “regenerative treatment” is one universal category.

Procedure literacy means understanding what tissue is injured, how severe the problem is, what the evidence supports, and what physical demands the patient must regain. PRP and MFAT are tools—not guarantees, shortcuts, or substitutes for diagnosis.

First Rule: Treat the Tissue, Not the Job Title

A picker’s painful shoulder could reflect rotator cuff tendinopathy, a partial tear, bursitis, arthritis, cervical nerve irritation, or another problem. A technician’s painful knee could involve tendon overload, meniscal injury, cartilage degeneration, osteoarthritis, ligament damage, or referred pain.

Before discussing an injection, care starts with history, examination, functional testing, and imaging when appropriate. The team also considers prior treatment, health history, recovery capacity, and job demands.

Beneficence means choosing an option that supports function and safety. Non-maleficence means avoiding unnecessary procedures. Autonomy means explaining realistic options so the patient—not marketing—drives the decision.

PRP: A Blood-Based Option for Selected Tendon Problems

Platelet-rich plasma starts with the patient’s own blood. Platelets help clotting and carry signaling proteins involved in tissue repair. PRP processing increases platelet concentration before the clinician places the prepared portion into a target area (American Academy of Orthopedic Surgeons [AAOS], n.d.).

What a PRP Visit Can Look Like

The exact system varies, but the sequence includes:

• Blood is drawn from the patient.
• A centrifuge separates blood components.
• The clinician prepares a platelet-concentrated portion.
• Ultrasound may guide placement.
• PRP is injected into the selected tendon or joint region.
• Temporary soreness can follow before rehabilitation progresses.

The goal is not instant numbing. AAOS notes that pain around the injection site can temporarily increase after PRP (AAOS, n.d.).

For a picker with rotator cuff tendinopathy or a selected partial-thickness injury, PRP may enter the conversation after diagnosis and rehabilitation. Evidence is mixed, but a 2026 meta-analysis found modest six-month pain and function advantages over corticosteroid injections in rotator cuff tendinopathy (Yuwarungsikul et al., 2026).

That does not mean PRP “wins” for every shoulder. Exercise remains foundational, and results depend on diagnosis, PRP preparation, disease stage, and rehabilitation.

MFAT: A Different Conversation for a Knee Joint Problem

Microfragmented adipose tissue uses a small amount of the patient’s own adipose tissue, harvested from the abdomen. It is mechanically processed, washed, prepared, and injected into a target joint.

This is more involved than a blood draw.

What an MFAT Procedure Can Involve

Published descriptions include:

• Local anesthesia at the harvest site.
• A small skin opening and limited fat harvest.
• Mechanical washing and microfragmentation.
• Sterile preparation of the knee.
• Ultrasound-guided intra-articular injection.
• Short-term soreness or bruising at the harvest site and knee.

A 2025 clinical report showed that adipose harvest, processing, and knee injection can be performed under local anesthesia, while describing expected bruising and discomfort around the harvest area (Varone et al., 2025).

For a technician with symptomatic knee osteoarthritis and substantial loading demands, MFAT may prompt discussion because the problem differs from a localized shoulder tendon injury. Yet “more involved” does not mean better.

The Evidence Demands Restraint

A randomized 2024 trial comparing PRP with MFAT for knee osteoarthritis found improvement in both groups at 12 months, with no significant difference between them (Baria et al., 2024). A larger placebo-controlled trial published in 2025 found that MFAT was not superior to saline injection for knee osteoarthritis outcomes (Barfod et al., 2025).

That is why procedure literacy matters.

Patients should be cautious when any clinic promises that an injection will regrow cartilage, rebuild a tendon, or guarantee avoidance of surgery. The FDA has warned that many products promoted under broad “regenerative medicine” language are not FDA-approved for orthopedic conditions (U.S. Food and Drug Administration [FDA], 2021).

Effective care separates biological possibility from proven clinical benefit.

Return to Work Is Built, Not Injected

An injection does not teach a picker to control an overhead load or a technician to tolerate kneeling, climbing, or a loaded squat. Rehabilitation converts symptom improvement into usable capacity.

After a Shoulder Procedure

Progression may include:

• Comfortable range of motion.
• Isometric and controlled strengthening.
• Rotator cuff and scapular loading.
• Repeated reaching.
• Gradual overhead work.
• Carrying and task-specific endurance.

After a Knee Procedure

Progression may include:

• Walking tolerance and swelling control.
• Quadriceps and hip strength.
• Step-ups and controlled lowering.
• Squats progressing deeper.
• Loaded carries.
• Kneeling, ladder, and job-specific drills.

The timeline should follow tissue response and function, not workplace pressure or gym ego. Returning too aggressively can overload recovering tissue; returning too cautiously can increase deconditioning.

Five Questions That Should Drive the Choice

Before choosing PRP, MFAT, or another strategy, ask:

1. What is the actual diagnosis?
2. Is the main problem tendon, cartilage, joint degeneration, instability, or something else?
3. What conservative care has already been completed?
4. What physical demands must be regained?
5. What does the evidence say for this tissue, procedure, and stage of injury?

Those questions protect athletes and workers from trend-based treatment.

Integrated Care Connects Performance and Safety

High-performance patients may need structural assessment, rehabilitation, imaging review, medication evaluation, metabolic testing, nutrition support, and medical oversight.

An integrated DC, NP, and MD model considers mechanical findings and medical risks together. Chiropractic and rehabilitation can address movement, load tolerance, and return-to-performance mechanics. Advanced practice and internal medicine evaluation can investigate healing or procedural risks when indicated.

This coordinated approach supports autonomy. Patients can compare options, ask about uncertainties, continue working with their existing medical team, and choose the path that matches their goals.

The Performance Takeaway

The picker’s shoulder and technician’s knee may both hurt during hard work, but similarity ends there. PRP may be considered for selected tendon problems. MFAT may be discussed for selected joint conditions. Neither should be sold as guaranteed regeneration.

The best plan starts with diagnosis, matches intervention to tissue severity, and finishes with progressive rehabilitation.

If you are an Amazon associate, warehouse worker, data-center technician, network installer, CrossFit athlete, or active worker with persistent tendon or joint pain, schedule a multidisciplinary evaluation. The goal is to understand the injury, protect your options, rebuild capacity, and return to the demands that matter.

---

References

American Academy of Orthopaedic Surgeons. (n.d.). Platelet-rich plasma (PRP). OrthoInfo.

Barfod, K. W., Blønd, L., Mikkelsen, R. K., Bagge, J., Hölmich, L. R., Kallemose, T., Troelsen, A., & Hölmich, P. (2025). Treatment of knee osteoarthritis with a single injection of autologous micro-fragmented adipose tissue is not superior to a placebo saline injection: A blinded randomised controlled trial with 2-year follow-up. British Journal of Sports Medicine, 59(17), 1219–1227.

Baria, M., Barker, T., Durgam, S., Pedroza, A., Flanigan, D., Jia, L., Kaeding, C., & Magnussen, R. (2024). Microfragmented adipose tissue is equivalent to platelet-rich plasma for knee osteoarthritis at 12 months posttreatment: A randomized controlled trial. Orthopaedic Journal of Sports Medicine, 12(3), 23259671241233916.

U.S. Food and Drug Administration. (2021). Important patient and consumer information about regenerative medicine therapies.

Varone, B. B., Fuller, H., Perini, D., Leal, D. P., Gobbi, R. G., & Demange, M. K. (2025). Micro-fragmented adipose tissue in the knee osteoarthritis under local anesthesia. Acta Ortopédica Brasileira, 33(1), e287060.

Yuwarungsikul, C., Phisalaphong, K., Thamrongskulsiri, N., Limskul, D., Tanpowpong, T., Kuptniratsaikul, S., & Itthipanichpong, T. (2026). Platelet-rich plasma provides modest but durable functional benefit over corticosteroid for rotator cuff tendinopathy: A systematic review and meta-analysis of randomized controlled trials. Knee Surgery, Sports Traumatology, Arthroscopy, 34(8), 2937–2950.